TRIAMINIC CHEST & NASAL CONGESTION OTC
Generic Name and Formulations:
Guaifenesin 50mg, phenylephrine HCl 2.5mg; per 5mL; liq; alcohol-free; tropical-flavored; contains sodium 3mg/5mL.
Novartis Consumer Health
Indications for TRIAMINIC CHEST & NASAL CONGESTION:
Cough and nasal congestion.
<4yrs: do not use. 4–6yrs: 5mL. 6–12yrs: 10mL. Repeat every 4 hours as needed; max 6 doses/24 hours.
Children <4yrs old. During or within 14 days of MAOIs.
Hypertension. Cardiovascular disease. Thyroid disease. Diabetes. Asthma. Lower respiratory disorders.
Expectorant + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized.
Nervousness, dizziness, insomnia.
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally